Employing genetic engineering for the treatment of infectious diseases means introducing specific genes that discretely inhibit or block the functions of target genes.
E. Charpentier and A. Doudna have made a landmark discovery for the CRISPR/Cas 9 method employed in genome editing, and received 2020's Nobel prize in chemistry.
